FDA panel backs Pfizer's COVID-19 vaccine for kids

The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. The FDA panel voted that the vaccine's benefits outweigh risks. (Oct. 26)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting